UK’s CMA Fines Four On Nortriptyline

Accord, Alissa, Lexon And King Fined Over £3.4m In Total

Four firms – Accord, Alissa, Lexon and King – have been fined by the UK’s Competition and Markets Authority over price-fixing and information-sharing activities related to the supply of nortriptyline.

CMA
The CMA has fined four firms over nortriptyline market sharing and information exchange • Source: Shutterstock

More from Regulation

More from Policy & Regulation